Life Sciences Partner Quoted in Bloomberg BNA Article on Digital Health Industry Facing Uncertain Federal Oversight

Life sciences partner Al Cacozza (Washington, D.C.) was quoted in an Aug. 29 Bloomberg BNA Health IT Law and Industry Report article discussing federal regulators’ testing the limits of their authority to oversee digital health technologies.

Mr. Cacozza explains that while the U.S. Food and Drug Administration has signaled in recent draft guidance that it won't regulate consumer health tools like fitness trackers, other federal agencies such as the Federal Trade Commission are taking an active role in overseeing the digital health industry.

Facing scrutiny from multiple agencies has left many digital health companies uncertain about how their products are regulated by the federal government.